193 related articles for article (PubMed ID: 26989846)
1. Dose Timing of an Angiotensin II Receptor Blocker/Calcium Channel Blocker Combination in Hypertensive Patients With Paroxysmal Atrial Fibrillation.
Kario K; Hoshide S; Uchiyama K; Yoshida T; Okazaki O; Noshiro T; Aoki H; Mizuno H; Matsumoto Y
J Clin Hypertens (Greenwich); 2016 Oct; 18(10):1036-1044. PubMed ID: 26989846
[TBL] [Abstract][Full Text] [Related]
2. Effect of nifedipine versus telmisartan on prevention of atrial fibrillation recurrence in hypertensive patients.
Du H; Fan J; Ling Z; Woo K; Su L; Chen S; Liu Z; Lan X; Zhou B; Xu Y; Chen W; Xiao P; Yin Y
Hypertension; 2013 Apr; 61(4):786-92. PubMed ID: 23438932
[TBL] [Abstract][Full Text] [Related]
3. Effect of tablets with a combination of telmisartan and amlodipine on patients with hypertension: the Cotalo study.
Ohishi M; Kawai T; Hayashi N; Kitano S; Katsuya T; Nagano M; Hirotani A; Yamamoto K; Kamide K; Rakugi H
Hypertens Res; 2013 Jul; 36(7):620-6. PubMed ID: 23425955
[TBL] [Abstract][Full Text] [Related]
4. A review of the benefits of early treatment initiation with single-pill combinations of telmisartan with amlodipine or hydrochlorothiazide.
Segura J; Ruilope LM
Vasc Health Risk Manag; 2013; 9():521-8. PubMed ID: 24082785
[TBL] [Abstract][Full Text] [Related]
5. Telmisartan plus amlodipine in patients with moderate or severe hypertension: results from a subgroup analysis of a randomized, placebo-controlled, parallel-group, 4 x 4 factorial study.
Littlejohn TW; Majul CR; Olvera R; Seeber M; Kobe M; Guthrie R; Oigman W;
Postgrad Med; 2009 Mar; 121(2):5-14. PubMed ID: 19332958
[TBL] [Abstract][Full Text] [Related]
6. Review: a single-pill combination of telmisartan plus amlodipine for the treatment of hypertension.
Guthrie RM
Postgrad Med; 2011 Nov; 123(6):58-65. PubMed ID: 22104454
[TBL] [Abstract][Full Text] [Related]
7. Age-related difference in the sleep pressure-lowering effect between an angiotensin II receptor blocker and a calcium channel blocker in Asian hypertensives: the ACS1 Study.
Kario K; Hoshide S
Hypertension; 2015 Apr; 65(4):729-35. PubMed ID: 25646296
[TBL] [Abstract][Full Text] [Related]
8. Telmisartan/amlodipine: single-pill combination in hypertension.
Moen MD
Am J Cardiovasc Drugs; 2010; 10(6):401-12. PubMed ID: 21090832
[TBL] [Abstract][Full Text] [Related]
9. Effect of telmisartan on paroxysmal atrial fibrillation recurrence in hypertensive patients with normal or increased left atrial size.
Fogari R; Zoppi A; Maffioli P; Mugellini A; Preti P; Perrone T; Derosa G
Clin Cardiol; 2012 Jun; 35(6):359-64. PubMed ID: 22522403
[TBL] [Abstract][Full Text] [Related]
10. Results of treatment with telmisartan-amlodipine in hypertensive patients.
Littlejohn TW; Majul CR; Olvera R; Seeber M; Kobe M; Guthrie R; Oigman W;
J Clin Hypertens (Greenwich); 2009 Apr; 11(4):207-13. PubMed ID: 19614805
[TBL] [Abstract][Full Text] [Related]
11. Combination of amlodipine plus angiotensin receptor blocker or diuretics in high-risk hypertensive patients: a 96-week efficacy and safety study.
Ma L; Wang W; Zhao Y; Zhang Y; Deng Q; Liu M; Sun H; Wang J; Liu L
Am J Cardiovasc Drugs; 2012 Apr; 12(2):137-42. PubMed ID: 22329591
[TBL] [Abstract][Full Text] [Related]
12. Effect of the renin-angiotensin system or calcium channel blockade on the circadian variation of heart rate variability, blood pressure and circulating catecholamines in hypertensive patients.
Karas M; Lacourcière Y; LeBlanc AR; Nadeau R; Dubé B; Florescu M; Lamarre-Cliche M; Poirier L; Larochelle P; de Champlain J
J Hypertens; 2005 Jun; 23(6):1251-60. PubMed ID: 15894902
[TBL] [Abstract][Full Text] [Related]
13. [Blood pressure lowering efficacy of telmisartan and amlodipine taking on the morning or at bedtime: ABPM results].
Peng GC; Wang YF; Xiao Y; Chen JF; Yang Y; Ye YL; Sai SQ; Huang JX
Zhonghua Xin Xue Guan Bing Za Zhi; 2013 Jun; 41(6):484-7. PubMed ID: 24113040
[TBL] [Abstract][Full Text] [Related]
14. Comparison of the efficacy of morning versus evening administration of telmisartan in essential hypertension.
Hermida RC; Ayala DE; Fernández JR; Calvo C
Hypertension; 2007 Oct; 50(4):715-22. PubMed ID: 17635851
[TBL] [Abstract][Full Text] [Related]
15. Randomized trial of an increased dose of calcium channel blocker or angiotensin II type 1 receptor blocker as an add-on intensive depressor therapy in type 2 diabetes mellitus patients with uncontrolled essential hypertension: the ACADEMIE Study.
Imaizumi S; Shiga Y; Ogawa M; Sako H; Nagata Y; Matsunaga A; Shirotani T; Hoshino F; Yahiro E; Uehara Y; Morito N; Tanigawa H; Shimono D; Fukushima M; Sugihara H; Norimatsu K; Kusumoto T; Saku K; Miura SI;
Heart Vessels; 2019 Apr; 34(4):698-710. PubMed ID: 30406819
[TBL] [Abstract][Full Text] [Related]
16. Titration of telmisartan, but not addition of amlodipine, reduces urine albumin in diabetic patients treated with telmisartan-diuretic.
Kojima M; Ohashi M; Dohi Y; Kimura G
J Hypertens; 2013 Jan; 31(1):186-91. PubMed ID: 23047595
[TBL] [Abstract][Full Text] [Related]
17. Effects of telmisartan and amlodipine in combination on ambulatory blood pressure in stages 1-2 hypertension.
White WB; Littlejohn TW; Majul CR; Oigman W; Olvera R; Seeber M; Schumacher H; Mancia G
Blood Press Monit; 2010 Aug; 15(4):205-12. PubMed ID: 20613496
[TBL] [Abstract][Full Text] [Related]
18. Combination therapy of angiotensin II receptor blocker and calcium channel blocker exerts pleiotropic therapeutic effects in addition to blood pressure lowering: amlodipine and candesartan trial in Yokohama (ACTY).
Maeda A; Tamura K; Kanaoka T; Ohsawa M; Haku S; Azushima K; Dejima T; Wakui H; Yanagi M; Okano Y; Fujikawa T; Toya Y; Mizushima S; Tochikubo O; Umemura S
Clin Exp Hypertens; 2012; 34(4):249-57. PubMed ID: 22571446
[TBL] [Abstract][Full Text] [Related]
19. Chronotherapy with valsartan/amlodipine fixed combination: improved blood pressure control of essential hypertension with bedtime dosing.
Hermida RC; Ayala DE; Fontao MJ; Mojón A; Fernández JR
Chronobiol Int; 2010 Jul; 27(6):1287-303. PubMed ID: 20653455
[TBL] [Abstract][Full Text] [Related]
20. Randomized trial of angiotensin II-receptor blocker vs. dihydropiridine calcium channel blocker in the treatment of paroxysmal atrial fibrillation with hypertension (J-RHYTHM II study).
Yamashita T; Inoue H; Okumura K; Kodama I; Aizawa Y; Atarashi H; Ohe T; Ohtsu H; Kato T; Kamakura S; Kumagai K; Kurachi Y; Koretsune Y; Saikawa T; Sakurai M; Sato T; Sugi K; Nakaya H; Hirai M; Hirayama A; Fukatani M; Mitamura H; Yamazaki T; Watanabe E; Ogawa S;
Europace; 2011 Apr; 13(4):473-9. PubMed ID: 21148662
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
